SCHEMBL868288

SCHEMBL868288

O=C1CCCCCCCCCCCCCCC1=O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
TRIM24 O15164 2/20 0.57
TRIM33 Q9UPN9 2/20 0.57
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
CYP2A6 P11509 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
KMT2A Q03164 3/20 0.36
CRBN Q96SW2 2/20 0.35
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
FKBP5 Q13451 1/20 0.35
MEN1 O00255 2/20 0.33
PRKCI P41743 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PLK1 P53350 1/20 0.32
CSNK2A1 P68400 1/20 0.32
PLK3 Q9H4B4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2944823 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL7178525 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL14672517 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL10391044 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL1552637 1.00
SCHEMBL28579421 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL9576029 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL2493977 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL2322944 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB
SCHEMBL482626 1.00 ALDH1A1 (0.57) ALDH1A1TRIM24TRIM33MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313692-B1 NOVEL MACROCYCLIC KETONES SYMRISE GMBH & CO KG (DE) 2005-07-20 EP claimed
US-6815413-B2 SATURATED OR UNSATURATED CYCLOHEXADECANONES ARE GRAND FRAGRANCES WITH MUSCONE NOTE WITH WHICH PERFUMES WITH NEW ODOR NOTES CAN BE PREPARED SYMRISE GMBH & CO. KG (DE) 2004-11-09 US claimed
EP-1313692-A1 NOVEL MACROCYCLIC KETONES HAARMANN & REIMER GMBH (DE) 2003-05-28 EP claimed
US-20020055453-A1 Novel macrocyclic ketones SYMRISE GMBH & CO. KG (DE) 2002-05-09 US claimed
WO-2002012157-A1 NOVEL MACROCYCLIC KETONES HAARMANN & REIMER GMBH (DE) 2002-02-14 WO claimed
EP-4520867-A2 ARTICLES FORMED OF PULP BASE MATERIALS WITH MODULATED SCENT RELEASE Enviroscent, Inc. (US) 2025-03-12 EP disclosed
US-20250049978-A1 Articles Formed of Pulp Base Materials With Modulated Scent Release ENVIROSCENT, INC. 2025-02-13 US disclosed
WO-2024242850-A1 DISSOLVABLE NANOCELLULOSE SHEET BERKLEY MEDICAL RESOURCES, INC. (US) 2024-11-28 WO disclosed
US-20240384470-A1 DISSOLVABLE NANOCELLULOSE SHEET BERKLEY MEDICAL RESOURCES, INC. (US) 2024-11-21 US disclosed
EP-4464763-A1 DISSOLVABLE NANOCELLULOSE SHEET Berkley Medical Resources, Inc. (US) 2024-11-20 EP disclosed
US-12109340-B2 Formed three-dimensional matrix and associated coating providing modulated release of volatile compositions ENVIROSCENT, INC. (US) 2024-10-08 US disclosed
EP-3518992-B1 ARTICLES FORMED OF PULP BASE MATERIALS WITH MODULATED SCENT RELEASE ENVIROSCENT INC (US) 2024-08-28 EP disclosed
EP-1203577-A1 Methods of fragrancing a surface THE PROCTER & GAMBLE COMPANY (US) 2002-05-08 EP disclosed
WO-2002034225-A1 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-05-02 WO disclosed
WO-2002034226-A1 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-05-02 WO disclosed
WO-2002034227-A1 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2002-05-02 WO disclosed
WO-2002012157-A1 NOVEL MACROCYCLIC KETONES HAARMANN & REIMER GMBH (DE) 2002-02-14 WO disclosed
WO-2001093815-A2 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-12-13 WO disclosed
WO-2001093814-A2 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-12-13 WO disclosed
WO-2001093813-A2 FRAGRANCE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2001-12-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020055453-A1 Novel macrocyclic ketones FASN, KCNK5, NOTUM ALDH1A1 762/4885TRIM24 2821/4885TRIM33 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.